You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Trimer 6931

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in United States (FP conjugate vaccine (25 mcg), FP conjugate vaccine (200 mcg), Trimer 6931 (100 mcg))

Not yet recruiting
  • HIV
  • FP conjugate vaccine (25 mcg)
  • +5 more
  • Los Angeles, California
  • +6 more
Jul 19, 2022

HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

Suspended
  • HIV Infections
  • BG505 MD39.3 mRNA
  • +2 more
  • Birmingham, Alabama
  • +9 more
Feb 1, 2023

Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)

Not yet recruiting
  • Hiv
  • V3G CH848 Pr-NP1 60mcg
  • +5 more
  • Birmingham, Alabama
  • +5 more
Jun 5, 2023

HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

Recruiting
  • HIV-1-infection
  • INO-6160, 2 mg
  • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
  • New York, New York
  • +2 more
Apr 13, 2023

COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

Recruiting
  • COVID-19
  • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
  • Guangzhou, Guangzhou, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023

HIV Trial in Columbus, Pittsburgh (Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, Placebo control for Trimer 4571 vaccine

Recruiting
  • HIV Infections
  • Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant
  • +3 more
  • Columbus, Ohio
  • +1 more
Apr 10, 2022

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

HIV Trial in Daytona Beach (CPT31, Placebo)

Completed
  • HIV Infections
  • Daytona Beach, Florida
    Covance Clinical Research Unit Inc.
Mar 10, 2022

Malignant Pleural Effusions Trial in Australia (SCB-313)

Completed
  • Malignant Pleural Effusions
  • Liverpool, New South Wales, Australia
  • +3 more
Feb 1, 2022

HIV Trial in United States (N332-GT5 gp140 (IM, Bolus), N332-GT5 gp140 (IM, Fractioned), N332-GT5 gp140 (SC, Bolus))

Not yet recruiting
  • HIV
  • N332-GT5 gp140 (IM, Bolus)
  • +7 more
  • San Francisco, California
  • +7 more
Sep 8, 2023

Peritoneal Malignancies Trial in Australia (SCB-313)

Completed
  • Peritoneal Malignancies
  • Liverpool, New South Wales, Australia
  • +4 more
Oct 18, 2021

Covid19 Trial in Porto Alegre, Rio De Janeiro, Natal (ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca), CoronaVac (Sinovac

Not yet recruiting
  • Covid19
  • ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca)
  • +2 more
  • Porto Alegre, Rio De Grande Do Sul, Brazil
  • +2 more
Oct 19, 2021

Human Immunodeficiency Virus Prevention, Human Immunodeficiency Virus (HIV) Trial run by the NIAID (VRC-HIVRGP096-00-VP, Alum

Completed
Has Results
  • Human Immunodeficiency Virus Prevention
  • Human Immunodeficiency Virus (HIV)
  • VRC-HIVRGP096-00-VP
  • Alum Adjuvant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 6, 2021